Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Low level of exosomal long non-coding RNA HOTTIP is a prognostic biomarker in colorectal cancer.

Oehme F, Krahl S, Gyorffy B, Muessle B, Rao V, Greif H, Ziegler N, Lin K, Thepkaysone ML, Polster H, Tonn T, Schneider M, Weitz J, Baenke F, Kahlert C.

RNA Biol. 2019 Oct;16(10):1339-1345. doi: 10.1080/15476286.2019.1637697. Epub 2019 Jul 7.

PMID:
31251124
2.

Expression of Glypican 3 is an Independent Prognostic Biomarker in Primary Gastro-Esophageal Adenocarcinoma and Corresponding Serum Exosomes.

Rahbari M, Pecqueux M, Aust D, Stephan H, Tiebel O, Chatzigeorgiou A, Tonn T, Baenke F, Rao V, Ziegler N, Greif H, Lin K, Weitz J, Rahbari NN, Kahlert C.

J Clin Med. 2019 May 16;8(5). pii: E696. doi: 10.3390/jcm8050696.

3.

Genome-wide association analysis of diverticular disease points towards neuromuscular, connective tissue and epithelial pathomechanisms.

Schafmayer C, Harrison JW, Buch S, Lange C, Reichert MC, Hofer P, Cossais F, Kupcinskas J, von Schönfels W, Schniewind B, Kruis W, Tepel J, Zobel M, Rosendahl J, Jacobi T, Walther-Berends A, Schroeder M, Vogel I, Sergeev P, Boedeker H, Hinrichsen H, Volk A, Erk JU, Burmeister G, Hendricks A, Hinz S, Wolff S, Böttner M, Wood AR, Tyrrell J, Beaumont RN, Langheinrich M, Kucharzik T, Brezina S, Huber-Schönauer U, Pietsch L, Noack LS, Brosch M, Herrmann A, Thangapandi RV, Schimming HW, Zeissig S, Palm S, Focke G, Andreasson A, Schmidt PT, Weitz J, Krawczak M, Völzke H, Leeb G, Michl P, Lieb W, Grützmann R, Franke A, Lammert F, Becker T, Kupcinskas L, D'Amato M, Wedel T, Datz C, Gsur A, Weedon MN, Hampe J.

Gut. 2019 May;68(5):854-865. doi: 10.1136/gutjnl-2018-317619. Epub 2019 Jan 19.

PMID:
30661054
4.

Correction to: FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences.

Plodeck V, Rahbari NN, Weitz J, Radosa CG, Laniado M, Hoffmann RT, Zöphel K, Beuthien-Baumann B, Kotzerke J, van den Hoff J, Platzek I.

Eur Radiol. 2019 Feb;29(2):1064. doi: 10.1007/s00330-018-5677-7.

PMID:
30083813
5.

FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences.

Plodeck V, Rahbari NN, Weitz J, Radosa CG, Laniado M, Hoffmann RT, Zöphel K, Beuthien-Baumann B, Kotzerke J, van den Hoff J, Platzek I.

Eur Radiol. 2019 Jan;29(1):422-428. doi: 10.1007/s00330-018-5589-6. Epub 2018 Jul 6. Erratum in: Eur Radiol. 2018 Aug 6;:.

PMID:
29980927
6.

Validation of prognostic risk scores for patients undergoing resection for pancreatic cancer.

Adamu M, Nitschke P, Petrov P, Rentsch A, Distler M, Reissfelder C, Welsch T, Saeger HD, Weitz J, Rahbari NN.

Pancreatology. 2018 May 21. pii: S1424-3903(18)30110-8. doi: 10.1016/j.pan.2018.05.005. [Epub ahead of print]

PMID:
29866508
7.

Transferability of laparoscopic skills using the virtual reality simulator.

Yang C, Kalinitschenko U, Helmert JR, Weitz J, Reissfelder C, Mees ST.

Surg Endosc. 2018 Oct;32(10):4132-4137. doi: 10.1007/s00464-018-6156-6. Epub 2018 Mar 30.

PMID:
29602986
8.

Impaired laparoscopic performance of novice surgeons due to phone call distraction: a single-centre, prospective study.

Yang C, Heinze J, Helmert J, Weitz J, Reissfelder C, Mees ST.

Surg Endosc. 2017 Dec;31(12):5312-5317. doi: 10.1007/s00464-017-5609-7. Epub 2017 Jun 8.

PMID:
28597285
9.

Detailed resolution analysis reveals spatial T cell heterogeneity in the invasive margin of colorectal cancer liver metastases associated with improved survival.

Berthel A, Zoernig I, Valous NA, Kahlert C, Klupp F, Ulrich A, Weitz J, Jaeger D, Halama N.

Oncoimmunology. 2017 Feb 23;6(3):e1286436. doi: 10.1080/2162402X.2017.1286436. eCollection 2017.

10.

Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients.

Klupp F, Neumann L, Kahlert C, Diers J, Halama N, Franz C, Schmidt T, Koch M, Weitz J, Schneider M, Ulrich A.

BMC Cancer. 2016 Jul 18;16:494. doi: 10.1186/s12885-016-2515-7.

11.

Exosomes: novel implications in diagnosis and treatment of gastrointestinal cancer.

Rahbari M, Rahbari N, Reissfelder C, Weitz J, Kahlert C.

Langenbecks Arch Surg. 2016 Dec;401(8):1097-1110. Epub 2016 Jun 24. Review.

PMID:
27342853
12.

Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.

Halama N, Zoernig I, Berthel A, Kahlert C, Klupp F, Suarez-Carmona M, Suetterlin T, Brand K, Krauss J, Lasitschka F, Lerchl T, Luckner-Minden C, Ulrich A, Koch M, Weitz J, Schneider M, Buechler MW, Zitvogel L, Herrmann T, Benner A, Kunz C, Luecke S, Springfeld C, Grabe N, Falk CS, Jaeger D.

Cancer Cell. 2016 Apr 11;29(4):587-601. doi: 10.1016/j.ccell.2016.03.005.

13.

Prolyl Hydroxylase 3 Attenuates MCL-1-Mediated ATP Production to Suppress the Metastatic Potential of Colorectal Cancer Cells.

Radhakrishnan P, Ruh N, Harnoss JM, Kiss J, Mollenhauer M, Scherr AL, Platzer LK, Schmidt T, Podar K, Opferman JT, Weitz J, Schulze-Bergkamen H, Koehler BC, Ulrich A, Schneider M.

Cancer Res. 2016 Apr 15;76(8):2219-30. doi: 10.1158/0008-5472.CAN-15-1474. Epub 2016 Feb 26.

14.

Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.

Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari N, Reissfelder C, Pilarsky C, Fraga MF, Piwnica-Worms D, Kalluri R.

Nature. 2015 Jul 9;523(7559):177-82. doi: 10.1038/nature14581. Epub 2015 Jun 24.

15.

Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma.

Klupp F, Diers J, Kahlert C, Neumann L, Halama N, Franz C, Schmidt T, Lasitschka F, Warth A, Weitz J, Koch M, Schneider M, Ulrich A.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1548-55. doi: 10.1245/s10434-015-4485-4. Epub 2015 Mar 13.

PMID:
25773877
16.

Salinomycin inhibits growth of pancreatic cancer and cancer cell migration by disruption of actin stress fiber integrity.

Schenk M, Aykut B, Teske C, Giese NA, Weitz J, Welsch T.

Cancer Lett. 2015 Mar 28;358(2):161-169. doi: 10.1016/j.canlet.2014.12.037. Epub 2014 Dec 18.

PMID:
25529011
17.

Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer.

Kahlert C, Fiala M, Musso G, Halama N, Keim S, Mazzone M, Lasitschka F, Pecqueux M, Klupp F, Schmidt T, Rahbari N, Schölch S, Pilarsky C, Ulrich A, Schneider M, Weitz J, Koch M.

Oncotarget. 2014 Dec 30;5(24):12978-89.

18.

Prospective evaluation of the International Study Group for Liver Surgery definition of bile leak after a liver resection and the role of routine operative drainage: an international multicentre study.

Brooke-Smith M, Figueras J, Ullah S, Rees M, Vauthey JN, Hugh TJ, Garden OJ, Fan ST, Crawford M, Makuuchi M, Yokoyama Y, Büchler M, Weitz J, Padbury R.

HPB (Oxford). 2015 Jan;17(1):46-51. doi: 10.1111/hpb.12322. Epub 2014 Jul 24.

19.

Peritoneal dissemination of a gastric API2-MALT1-positive MALT lymphoma.

Krautz C, Kuithan F, Dobroschke J, Nagel I, Hartmann S, Aust DE, Baretton G, Weitz J, Reissfelder C.

J Clin Pathol. 2014 Aug;67(8):746-8. doi: 10.1136/jclinpath-2014-202297. Epub 2014 Jun 18. No abstract available.

PMID:
24942800
20.

Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer.

Kahlert C, Melo SA, Protopopov A, Tang J, Seth S, Koch M, Zhang J, Weitz J, Chin L, Futreal A, Kalluri R.

J Biol Chem. 2014 Feb 14;289(7):3869-75. doi: 10.1074/jbc.C113.532267. Epub 2014 Jan 7.

Supplemental Content

Loading ...
Support Center